Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 18 | 4 | CHEMISTRY, ANALYTICAL//TOXICOLOGY//ENVIRONMENTAL SCIENCES | 697102 |
| 627 | 3 | ACCREDITATION AND QUALITY ASSURANCE//PRESSURE SENSITIVE PAINT//CHEMISTRY, ANALYTICAL | 12679 |
| 2308 | 2 | ACCREDITATION AND QUALITY ASSURANCE//PROFICIENCY TESTING//HYDROCHLOROTHIAZIDE | 4795 |
| 33090 | 1 | PHARMA TECH DEV BIOTECH EUROPE//CONTROLLER CONFIGURATION//MULTIVARIATE BAYESIAN PREDICTIVE APPROACH | 143 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | PHARMA TECH DEV BIOTECH EUROPE | address | 661196 | 2% | 100% | 3 |
| 2 | CONTROLLER CONFIGURATION | authKW | 440797 | 1% | 100% | 2 |
| 3 | MULTIVARIATE BAYESIAN PREDICTIVE APPROACH | authKW | 440797 | 1% | 100% | 2 |
| 4 | PHARMACEUTICAL QUALITY BY DESIGN | authKW | 440797 | 1% | 100% | 2 |
| 5 | RELIABLE OPERATING REGION | authKW | 440797 | 1% | 100% | 2 |
| 6 | QUALITY BY DESIGN | authKW | 428018 | 20% | 7% | 29 |
| 7 | CRITICAL PROCESS PARAMETER | authKW | 396715 | 2% | 60% | 3 |
| 8 | WYETH BIOTECH | address | 293863 | 1% | 67% | 2 |
| 9 | BIOPHARM INTERNATIONAL | journal | 268400 | 18% | 5% | 26 |
| 10 | CRITICAL QUALITY ATTRIBUTE | authKW | 250445 | 3% | 23% | 5 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Biotechnology & Applied Microbiology | 1498 | 43% | 0% | 62 |
| 2 | Pharmacology & Pharmacy | 1343 | 56% | 0% | 80 |
| 3 | Chemistry, Medicinal | 116 | 9% | 0% | 13 |
| 4 | Cell & Tissue Engineering | 65 | 2% | 0% | 3 |
| 5 | Operations Research & Management Science | 55 | 5% | 0% | 7 |
| 6 | Engineering, Industrial | 50 | 3% | 0% | 5 |
| 7 | Biochemical Research Methods | 48 | 7% | 0% | 10 |
| 8 | Engineering, Chemical | 33 | 8% | 0% | 11 |
| 9 | Food Science & Technology | 15 | 5% | 0% | 7 |
| 10 | Engineering, General | 13 | 3% | 0% | 4 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | PHARMA TECH DEV BIOTECH EUROPE | 661196 | 2% | 100% | 3 |
| 2 | WYETH BIOTECH | 293863 | 1% | 67% | 2 |
| 3 | AREA CORPORAT QUALITAT | 220399 | 1% | 100% | 1 |
| 4 | BIOL MSAT | 220399 | 1% | 100% | 1 |
| 5 | BIOPHARM RD UNIT | 220399 | 1% | 100% | 1 |
| 6 | BIOPHARMA OPERAT | 220399 | 1% | 100% | 1 |
| 7 | EUROPEAN FEDERAT PHARMACEUT SCI EUFEPS | 220399 | 1% | 100% | 1 |
| 8 | FERMENTAT PROC DEV | 220399 | 1% | 100% | 1 |
| 9 | GMS TEC SHARED SERV | 220399 | 1% | 100% | 1 |
| 10 | HIV VIRUS VACCINE PROGRAM 1 | 220399 | 1% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | BIOPHARM INTERNATIONAL | 268400 | 18% | 5% | 26 |
| 2 | BIOPHARM-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT | 31120 | 3% | 3% | 5 |
| 3 | BIOLOGICALS | 7629 | 5% | 0% | 7 |
| 4 | ADVANCES IN BIOCHEMICAL ENGINEERING-BIOTECHNOLOGY | 5550 | 2% | 1% | 3 |
| 5 | JOURNAL OF PHARMACEUTICAL INNOVATION | 3967 | 1% | 1% | 2 |
| 6 | QUALITY PROGRESS | 2458 | 2% | 0% | 3 |
| 7 | BIOTECHNOLOGY PROGRESS | 2281 | 5% | 0% | 7 |
| 8 | BIOPHARM-THE TECHNOLOGY & BUSINESS OF BIOPHARMACEUTICALS | 2202 | 1% | 1% | 1 |
| 9 | INTECH | 1898 | 1% | 1% | 1 |
| 10 | DRUG INFORMATION JOURNAL | 1797 | 2% | 0% | 3 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |